Pediatric Blood & Cancer
Overview
Pediatric Blood & Cancer is a renowned peer-reviewed medical journal that focuses on the diagnosis, treatment, and prevention of blood disorders and cancer in children and adolescents. It publishes cutting-edge research, clinical trials, and case studies, providing valuable insights into pediatric hematology and oncology. The journal serves as a vital resource for healthcare professionals, researchers, and policymakers dedicated to improving the care and outcomes for young patients affected by these conditions.
Details
Details
Abbr.
Pediatr Blood Cancer
Start
2004
End
Continuing
Frequency
Fourteen no. a year
p-ISSN
1545-5009
e-ISSN
1545-5017
Country
United States
Language
English
Specialties
Oncology
Pediatrics
Hematology
Pediatrics
Hematology
Metrics
Metrics
h-index / Ranks: 1995
128
SJR / Ranks: 3856
992
CiteScore / Ranks: 5069
5.00
JIF / Ranks: 3189
3.2
Recent Articles
1.
Othman M, Emmanuel J, Pamungkas K, Sutthatarn P, Nguyen T, Moreno A, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31599.
PMID: 40079682
Purpose: To profile the surgical management of pediatric renal tumors rendered in low- and middle-income countries (LMICs) of the Asia Pacific region, which are not currently affiliated to any pediatric...
2.
3.
Mahapatra A, Sahana N, Windsor R, Jackson T
Pediatr Blood Cancer
. 2025 Mar;
:e31651.
PMID: 40065433
Introduction: Febrile neutropenia (FN) episodes in sarcoma patients may be due to potentially life-threatening microbiologically defined infection (MDI). Clinical decision rules (CDRs) such as the Australian-UK-Swiss (AUS) rule have been...
4.
Place A, Karol S, Forlenza C, Cooper T, Fraser C, Cario G, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31630.
PMID: 40062648
Background: Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and although many patients respond to induction therapy, those who relapse or have refractory disease face a poor prognosis....
5.
Ramirez-Cuebas G, Abdullahi S, Gambo S, Murtala H, Kabir H, Shamsu K, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31637.
PMID: 40062628
Background: In this planned ancillary analysis of our completed clinical trial, we hypothesized that among older children with sickle cell anemia (SCA) and severe acute malnutrition, those with higher levels...
6.
Palese M, Advani R, Biney-Amissah D, Birz S, Collins G, Hoppe R, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31646.
PMID: 40059286
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare, indolent lymphoma lacking an evidence-based standard of care. NLPHL research has been challenging due to its classification, unique features, and rarity. The...
7.
Shdaifat E
Pediatr Blood Cancer
. 2025 Mar;
:e31650.
PMID: 40059285
Objective: This study aimed to examine the demographic characteristics of informal caregivers of pediatric patients with sickle cell disease. The background characteristics of both caregivers and care recipients were analyzed,...
8.
Fitski M, Bokkerink G, Davidoff A, Murphy A, Abdelhafeez A, Krauel L, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31636.
PMID: 40059283
Background And Aim: Current pediatric renal tumor treatment protocols allow for nephron-sparing surgery (NSS) for unilateral disease only under strict conditions. Oncological guidelines do not account for surgical feasibility, however,...
9.
Monroe C, Muniz J, Leong T, Lewis R, Castellino S
Pediatr Blood Cancer
. 2025 Mar;
:e31641.
PMID: 40055873
Background: Low socioeconomic groups and racial/ethnic minorities continue to experience pediatric cancer outcome disparities, and remain underrepresented in clinical trials. It is vital to understand why underrepresentation exists and to...
10.
Withey K, Brougham M, Paciarotti I, McKenzie J, Wilson D, Revuelta Iniesta R
Pediatr Blood Cancer
. 2025 Mar;
:e31645.
PMID: 40055871
Background: Given the limited research on folate and ferritin status in children with cancer undergoing treatment, we investigated the prevalence of abnormalities and their impact on clinical outcomes and treatment...